Looks like you clickedhttps://www.urotoday.com/conference-highlights/asco-2019-annual-meeting/asco-2019-prostate-cancer/112893-asco-2019-taxomet-a-french-prospective-multicenter-randomized-controlled-phase-ii-study-comparing-docetaxel-plus-metformin-versus-docetaxel-plus-placebo-in-mcrpc-oncologist-perspective.html?utm_source=newsletter_6891&utm_medium=email&utm_campaign=where-the-treatment-paradigm-stands-and-what-to-expect-from-apccc-2019
If you do not want to visit that page, you can close this browser tab.
